LONG TERM ORAL ETOPOSIDE AS SECOND LINE THERAPY IN RECURRENT EPITHELIAL CARCINOMA OF THE OVARY
There is a continuing need to identify new agents that are active in ovarian cancer. Etoposide is a derivative of the plant alkaloid epipodophyllotoxin. The availability of etoposide in oral preparation allows prolonged administration by the oral route. In this study, activity and toxicity of etopos...
Main Authors: | A. S. Moosavi, A. Tehranian, N. Behtash, M. Modares Gilani F. Ghaemmaghami |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2006-02-01
|
Series: | Acta Medica Iranica |
Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/3129 |
Similar Items
-
LONG TERM ORAL ETOPOSIDE AS SECOND LINE THERAPY IN RECURRENT EPITHELIAL CARCINOMA OF THE OVARY
by: A. S. Moosavi, et al.
Published: (2006-05-01) -
Long Term Oral Etoposide As Second-Line Therapy In Recurrent Epithelial Carcinoma Of The Ovary
by: Azam Sadat Moosavi, et al.
Published: (2005-01-01) -
Gemcitabine- Carboplatin Combination therapy for recurrent ovarian cancer: a prospective study
by: Modares Gilani M, et al.
Published: (2008-10-01) -
Temozolomide and oral etoposide in children with recurrent malignant brain tumors
by: Antonio Ruggiero, et al.
Published: (2020-06-01) -
Etoposide Therapy for Recurrent Gliomas
by: J Gordon Millichap
Published: (1997-06-01)